Monday 8 March 2021
Home      All news      Contact us      RSS     
healtheuropa - 19 days ago

Xphyto expects approval for 25-minute COVID-19 RT-PCR test

XPhyto Therapeutics Corp. and its exclusive German diagnostics development partner, 3a-diagnostics GmbH, are expecting approval of the commercial in vitro rapid point-of-care COVID-19 RT-PCR Test System (COVID-ID Lab) by early March. XPhyto Therapeutics Corp. and 3a-diagnostics GmbH (3a) have announced that all actions and procedures required for its European regulatory application for the rapid point-of-care [ ] The post Xphyto expects approval for 25-minute COVID-19 RT-PCR test appeared first on Health Europa.


Latest News
Hashtags:   

Xphyto

 | 

expects

 | 

approval

 | 

minute

 | 

COVID

 | 

Sources